BOSTON, November 23, 2020— A new study published in LGBT Health found that frequent exposure to negative depictions of transgender people in the media was significantly associated with clinical symptoms of depression, anxiety, global psychological distress, and post-traumatic stress disorder …
The 2020 Judy Bradford LGBTQIA+ Women’s Health Research Forum was hosted virtually by The Fenway Institute on October 30th and 31st. The forum brought together community members, healthcare providers, and researchers to discuss strategies to improve engagement in primary and …
Boston, October 27, 2020 – The LGBT Aging Project, a program of The Fenway Institute at Fenway Health, announced today that it has received a $10,000 grant from Eastern Bank Charitable Foundation (EBCF). The grant is part of a commitment …
October 26 is Intersex Awareness Day, an annual observance that highlights the human rights issues faced by intersex people around the world. The date was chosen to mark the anniversary of the first public demonstration by intersex people in North …
On October 16–19, 2020, The Division of Education and Training at The Fenway Institute hosted the 6th annual Advancing Excellence in Transgender Health Conference. This year’s conference was held virtually and saw a record number of 578 registrants from …
WASHINGTON, OCTOBER 21 — More Americans identify as lesbian, gay, bisexual, transgender, queer, intersex, or other non-binary identities (LGBTQI+) than ever before, but significant gaps remain in data collection and understanding of their well-being, says a new report from the …
The COVID-19 pandemic has devastated the world on a scale not seen in a hundred years. As we enter the final months of 2020, with cases and deaths continuing to rise across the US, researchers are working round the clock …
BOSTON, October 7, 2020—Today, The Fenway Institute of Fenway Health released a policy brief demonstrating that during its four years in office, the Trump Administration enacted more anti-LGBTQIA+ policies than any previous administration in history. Titled “Trump-Pence Administration policies …
BOSTON, SEPTEMBER 30, 2020 — Fenway Health announces today that the Boston-based community health center has been activated as a late-stage clinical trial site for the CoVPN 3502 monoclonal antibody study to prevent COVID-19 disease among household members of recently …
BOSTON, September 8, 2020—Fenway Health announces today that it will participate in the Phase 3 clinical trial testing the efficacy of a vaccine developed by Oxford University and licensed to the pharmaceutical company, AstraZeneca to evaluate if the vaccine can …
